Clinical Trial Update: Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pregabalin to prevent acute pain syndrome in patients receiving paclitaxel; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Pain, Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2018-04-06